000			02135 a2200613 4500
005			20250518085201.0
264		0	_c20211105
008			202111s 0 0 eng d
022			_a1557-9077
024	7		_a10.1089/thy.2019.0453 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Jiaying
245	0	0	_aSurufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial. _h[electronic resource]
260			_bThyroid : official journal of the American Thyroid Association _c09 2020
300			_a1245-1253 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBiomarkers _xblood
650	0	4	_aCalcitonin _xblood
650	0	4	_aCarcinoma, Neuroendocrine _xdrug therapy
650	0	4	_aCell Differentiation
650	0	4	_aChina _xepidemiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aIodine Radioisotopes _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xmetabolism
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aThyroid Neoplasms _xdrug therapy
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aJi, Qinghai
700	1		_aBai, Chunmei
700	1		_aZheng, Xiangqian
700	1		_aZhang, Yuan
700	1		_aShi, Feng
700	1		_aLi, Xiaojiang
700	1		_aTang, Pingzhang
700	1		_aXu, Zhengang
700	1		_aHuang, Rui
700	1		_aHuang, Tao
700	1		_aPan, Yueyin
700	1		_aFan, Songhua
700	1		_aZhou, Jinghong
700	1		_aSu, Weiguo
773	0		_tThyroid : official journal of the American Thyroid Association _gvol. 30 _gno. 9 _gp. 1245-1253
856	4	0	_uhttps://doi.org/10.1089/thy.2019.0453 _zAvailable from publisher's website
999			_c30651675 _d30651675